Login

Healthcare

00:10:00
Navigating the Intersection of Politics and Medicine: Insights from a Health Ministry Veteran | Mr. Chi-Hsien Chan, CEO, Adimmune Corp .
00:10:00
Addex Therapeutics' Advancements in Allosteric Modulation and Collaborative Ventures in CNS Pharmaceuticals |Tim DyerCo , CEO, Addex Therapeutics Ltd.
00:10:00
Pioneering Immune Medicine and Driving Collaborative Health Tech Solutions. |Chad Robbin , CEO, Adaptive Biotechnologies.
00:10:00
Exploring Biotech Advancements and Talent Growth in Washington |Chad Robbin , CEO, Adaptive Biotechnologies.
00:10:00
Biopharmaceutical CEO discusses promising Phase 3 trial results of a novel antibiotic for Clostridioides difficile Infections with potential market impact exceeding $1B |David P Luci , CEO, Acurx Pharmaceuticals Inc.
00:10:00
Biotech CEO presents promising clinical trial results and upcoming milestones |Helen Tuvesson , CEO, Active Biotech AB
00:10:00
Developing Novel Therapy for Neurological Diseases Associated with Dysregulated Brain Cortisol|Steven Gourlay , CEO, Actinogen Medical Ltd.
00:10:00
In-depth discussion on neuro therapeutics and strategic priorities for the next 18 months by Actinogen Medical Ltd CEO|Steven Gourlay , CEO, Actinogen Medical Ltd.
00:10:00
Cutting-Edge Cancer Therapies and Financial Strategies at the Biotech Showcase in San Francisco| Sadesh Seth , CEO, Actinium Pharmaceuticals Inc.
00:10:00
Exploring the Landscape of Biotech Innovations| Gilles Avenard , CEO, Acticor Biotech SA.
00:10:00
Exploring Entrepreneurial Journeys and Industry Insights| Gilles Avenard , CEO, Acticor Biotech SA.
00:10:00
Exploring Science Advocacy and Influential Leadership in Neurological Disorders| Dr. Ron Cohen, CEO, Acorda Therapeutics Inc.
00:10:00
Navigating the Success and Future Prospects of a Promising Smoking Cessation Asset| John Bencich, CEO, Achieve Life Sciences Inc.
00:10:00
Developing a Promising Smoking Cessation Drug with Favorable Safety Profile for a Large Market Opportunity| John Bencich, CEO, Achieve Life Sciences Inc.
00:10:00
Advancing Therapeutic Solutions for Rare Diseases: Acer's Diverse Clinical Pipeline|Chris Schelling, CEO, Acer Therapeutics Inc.
00:10:00
Exploring the Intersection of Entrepreneurship and Alzheimer's Research: A Female Leader's Journey|Andrea Pfeifer, CEO, AC Immune SA.

© 2026 Nehu